Skip to main content
. Author manuscript; available in PMC: 2016 Feb 1.
Published in final edited form as: Am J Transplant. 2015 Oct 20;16(2):574–582. doi: 10.1111/ajt.13495

Table 2. Participants with CYP3A5 loss-of-function alleles observed.

Discovery cohort (n = 197) Validation cohort (n = 160)
rs776746 (*3)
 0 98 (49.8) 88 (55.0)
 1 77 (39.1) 59 (36.9)
 2 22 (11.2) 13 (8.1)
rs10264272 (*6)
 0 154 (78.2) 119 (74.4)
 1 42 (21.3) 39 (24.4)
 2 1 (0.5) 2 (1.3)
rs41303343 (*7)
 0 162 (82.2) 126 (78.8)
 1 31 (15.7) 34 (21.3)
 2 4 (2.0) 0 (0)
All 3 LoF alleles
 0 51 (25.9) 33 (20.6)
 1 88 (44.7) 92 (57.5)
 2 58 (29.4) 35 (21.9)

Data shown as n (%). LoF, loss of function.